Assignee
SUZHOU KANOVA BIOPHARMACEUTICAL CO LTD
CN·4 granted patents·2 pending applications·4 citations·filing 2017–2022
Top patents by PatentIndex Score
6 records- 0186US10858427B2Monoclonal antibody against both IL-17A and IL-17F and use of the sameSUZHOU KANOVA BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 8, 2020·4 cites·15 claims
- 0255US2024239892A1Anti-pd-1 polypeptides and their useSUZHOU KANOVA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0353US2024239887A1Anti-tigit antibodies and their useSUZHOU KANOVA BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0446US12258392B2Anti-IL-25 antibodies and use thereofSUZHOU KANOVA BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 25, 2025·0 cites·13 claims
- 0542US12358985B2Anti-B7S1 polypeptides and their useSUZHOU KANOVA BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 0642US12187800B2Anti-B7-H3 antibodySUZHOU KANOVA BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Jan 7, 2025·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when SUZHOU KANOVA BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →